Showing results (631-640 of 673) with videos related to

Sort By:
Pageof 68
Blood Advances|June 25, 2025
Efficacy and Safety of Thrombolysis for Pediatric Venous Thromboembolism: A Systematic Review and Meta-analysisHassan Kawtharany, Muayad Azzam, Aseel Alkhader, et al.
BMJ (Clinical Research Ed.)|May 29, 2025
Drug treatments for mild or moderate covid-19: systematic review and network meta-analysisSara Ibrahim, Reed A C Siemieniuk, María José Oliveros, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 8, 2022
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki DiseaseMark Gorelik, Sharon A Chung, Kaveh Ardalan, et al.
BMJ (Clinical Research Ed.)|January 14, 2021
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trialsSuetonia C Palmer, Britta Tendal, Reem A Mustafa, et al.
Blood Advances|February 9, 2021
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Canadian Journal of Kidney Health and Disease|February 21, 2020
Major Outcomes With Personalized Dialysate TEMPerature (MyTEMP): Rationale and Design of a Pragmatic, Registry-Based, Cluster Randomized Controlled TrialAhmed A Al-Jaishi, Christopher W McIntyre, Jessica M Sontrop, et al.
Arthritis Care & Research|March 8, 2022
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki DiseaseMark Gorelik, Sharon A Chung, Kaveh Ardalan, et al.
British Journal of Neurosurgery|September 2, 2021
Neurosurgery activity levels in the United Kingdom and republic of Ireland during the first wave of the covid-19 pandemic - a retrospective cross-sectional cohort studyGeorge E Richardson, Abdurrahman I Islim, Erminia Albanese, et al.
Blood Advances|September 2, 2021
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patientsAdam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Blood Advances|May 3, 2022
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patientsAdam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Pageof 68